Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1908 of 6351
-
Can a tiny bone cut shorten your time in braces?
Disease control CompletedIntraoral impressions with alginate will be taken at the start of treatment and plaster casts will be obtained by using ortho plaster. Separators will be passed mesial and distal to first molars to create space for band placement. After 7-10 days bands will be cemented on first m…
Sponsor: Foundation University Islamabad • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Brain shrinkage as a crystal ball for MS progression?
Knowledge-focused By invitation onlyPENTAGON is an observational, non-interventional, multicenter, prospective cohort study conducted at approximately 20 neurology centers and affiliated radiology centers across Germany. It investigates whether loss of thalamic volume (TVL) is an independent driver of disability pr…
Sponsor: Jung Diagnostics GmbH • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can we decode the hidden physical health struggles of autism?
Knowledge-focused OngoingAutistic patients have higher rates of co-morbid somatic symptoms. Thus, compared to the general population, they experience more health-related concerns, such as autoimmune disease, gastrointestinal disease, cardiovascular disease, and autonomic disorders. On average, an autisti…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Which steroid works better for chronic cough? a Head-to-Head trial aims to find out
Disease control CompletedChronic cough - a cough lasting eight weeks or longer - is one of the most common reasons people see a lung specialist. It can disturb sleep, make conversation difficult, and reduce quality of life. In many people, chronic cough occurs together with nose and sinus symptoms such …
Sponsor: Silesian University of Medicine • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New study: could a wearable heart monitor after fainting save lives?
Disease control Recruiting nowSyncope (fainting) is a common reason for emergency department (ED) presentation. Fainting can be caused by heart conditions such as irregular heart rhythm (arrhythmia) that can be life-threatening, structural heart problems, or serious conditions not related to the heart. The st…
Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy targets Hard-to-Treat lymphoma
Disease control CompletedThis study is an open-label Phase II trial of non-Hodgkin lymphoma patients receiving initial treatment with the immunomodulatory agent, pembrolizumab, plus low-dose (4 Gy x 5) involved-site radiotherapy. Eligible patients will have r/r disease with at least 2 sites of measurable…
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Peer power: new study boosts HIV prevention in minority men
Prevention CompletedThe objective of this study is to develop an effective peer-driven intervention (PDI) approach and assess its feasibility and efficacy on pre-exposure prophylaxis (PrEP) uptake among men who have sex with men.
Sponsor: The Miriam Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
Teens with sickle cell disease get a brain boost to prep for adult care
Symptom relief Recruiting nowRandomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) intervention to prepare adolescents with sickle cell disease for transition of care.
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Can a common arthritis drug silence Blast-Induced tinnitus?
Symptom relief Recruiting nowThe purpose of this multi-site research study is to determine if Etanercept, compared to a placebo, significantly reduces the severity of tinnitus (ringing in the ears) associated with history of blast and/or noise exposure or associated with Traumatic Brain Injury (TBI) and/or c…
Phase 2 • Sponsor: Wayne State University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could a vaccine train Kids' bodies to fight brain cancer?
Disease control OngoingPatients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells that express a protein called s…
Phase 1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New triple therapy shows promise for resistant cancers
Disease control CompletedThis is a multicenter, open-label, dose-escalation and efficacy/safety Phase I/II study to assess RP2D, safety, tolerability and anti-tumor activity of Sintilimab + afuresertib + nab-paclitaxel or docetaxel administered as a combination therapy. This study is designed to identif…
Phase 1/2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Sound waves vs. high blood pressure: new device shows promise
Disease control OngoingTo compare the antihypertensive effect of renal denervation with the Paradise™ system with that of a sham procedure in hypertensive patients receiving two antihypertensive drugs at the time of consent, and treated with a duo combination antihypertensive pill.
Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for rare clotting disorder: drug aims to prevent dangerous clots during surgery and delivery
Disease control Recruiting nowThe goal of this study is to assess the incidence of the composite of thrombotic events (TEs) and thromboembolic events (TEEs) in patients with congenital antithrombin deficiency under when they receive Atenativ for surgical procedures or parturition.
Phase 3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New imaging study reveals how drug tames Crohn's inflammation
Disease control CompletedCrohn's disease(CD),a type of inflammatory bowel disease(IBD), is a chronic intestinal recurrent inflammatory disease involving the entire digestive tract. And Ustekinumab, a monoclonal antibody against the p40 subunit of interleukin-12 and interleukin-23, is a newly targeted dru…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Pill vs. IV: could a new drug beat the standard for deadly lung fungus?
Disease control CompletedPulmonary mucormycosis is a serious illness with high morbidity and mortality (approximately 57%). Surgery and antifungal therapy are central in the management of mucormycosis. Unlike rhino-orbital mucormycosis, surgery is not feasible in several patients with pulmonary mucormyco…
Phase 2 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Laser light to the brain may lift depression
Symptom relief CompletedNote: This registration is retained as a historical study record. Updated study information and subsequent protocol modifications are available under ClinicalTrials.gov Identifier NCT06934135, which serves as the actively maintained study registration. The Near-Infrared Transcra…
Sponsor: Peruvian Clinical Research • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New hope for Hard-to-Treat lung cancer: targeted drug shows promise in early trial
Disease control OngoingThis is a Phase 1b, open-label, multi-center, dose-escalation and dose expansion study designed to evaluate the safety, pharmacokinetics (PK), and preliminary antitumor activity of furmonertinib in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with activ…
Phase 1 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Early diet coaching may cut gestational diabetes risk in at-risk moms
Prevention OngoingHealthy eating during pregnancy has favorable effects on markers related to diabetes (glucose tolerance) and is associated with lower gestational diabetes mellitus (GDM) risk. The cornerstone of GDM treatment is nutrition therapy but the latter often starts late in pregnancy and …
Sponsor: CHU de Quebec-Universite Laval • Aim: Prevention
Last updated Jun 26, 2026 14:59 UTC
-
New combo pill aims to curb weight gain in teens on antipsychotics
Disease control Recruiting nowTo compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine
Phase 3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug shows promise for Long-Term control of rare muscle disease
Disease control CompletedThe primary study objective is to evaluate medium- and long-term safety of HBM9161 in combination with background treatment for gMG patients through the observation on adverse events and laboratory abnormalities during study period.
Phase 3 • Sponsor: Harbour BioMed (Guangzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC